➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: October 24, 2020

DrugPatentWatch Database Preview

Details for Patent: 6,465,709

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,465,709 protect, and when does it expire?

Patent 6,465,709 protects SYNERA and is included in one NDA.

This patent has five patent family members in five countries.

Summary for Patent: 6,465,709
Title: Exothermic bandage
Abstract:The present invention relates to a multi-layer exothermic bandage comprising an oxygen-impermeable layer, a water-impermeable layer, a heating element layer comprising an oxidizable material, and an active agent layer; and the use thereof.
Inventor(s): Sun; Ying (Somerville, NJ), Oakeson; Ralph W. (Racine, WI), Wisniewski; Stephen J. (Doylestown, PA), Wang; Jonas C. T. (West Windsor, NJ)
Assignee: Johnson & Johnson Consumer Companies, Inc. (Skillman, NJ)
Application Number:09/611,865
Patent Claim Types:
see list of patent claims
Device; Use; Delivery;

Drugs Protected by US Patent 6,465,709

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,465,709

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 6076200   Start Trial
Canada 2375655   Start Trial
European Patent Office 1202691   Start Trial
Japan 2004510454   Start Trial
World Intellectual Property Organization (WIPO) 0103625   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.